CT coronary angiography: new risks for low-risk chest pain

Ryan Patrick Radecki1

  • 1Department of Emergency Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA. Ryan.P.Radecki@uth.tmc.edu

Insights

CT coronary angiography (CTCA) offers rapid triage for low-risk chest pain in the Emergency Department (ED). However, evidence for its added prognostic value, cost-effectiveness, and safety compared to traditional methods remains insufficient, warranting cautious adoption.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Radiology

Background:

  • Conservative management is common for low-risk chest pain.
  • CT coronary angiography (CTCA) has emerged as a rapid triage tool in the Emergency Department (ED).
  • Recent trials support routine CTCA use in the ED.

Purpose of the Study:

  • To evaluate the incremental prognostic value of CTCA.
  • To assess downstream costs and interventions associated with CTCA.
  • To analyze harms of CTCA, including radio-contrast and radiation exposure.

Main Methods:

  • Review of recent prominent trials on CTCA in the ED setting.
  • Analysis of prognostic data comparing CTCA with clinical and biomarker strategies.
  • Evaluation of economic impact and adverse events related to CTCA.

Main Results:

  • Studies failed to demonstrate incremental prognostic value of CTCA over existing strategies.
  • CTCA use was associated with additional downstream costs and interventions.
  • Harms related to radio-contrast and radiation exposure were identified.

Conclusions:

  • Routine use of CTCA for low-risk chest pain in the ED should be approached with caution.
  • The findings suggest potential overdiagnosis and iatrogenic harms similar to CT pulmonary angiography.
  • Further research is needed to clarify the true benefit-risk profile of CTCA in this setting.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...